Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
35.1%
% of BHCHX's 40 holdings also in PINK
24.5%
% of PINK's 56 holdings also in BHCHX
Overlap by Weight
Sector Drift (BHCHX minus PINK)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BHCHX |
Weight in PINK |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY AND COMPANY | 9.3% | 6.5% | 6.5% |
|
UNITEDHEALTH GROUP INCORPORATED | 7.3% | 5.4% | 5.4% |
|
INTUITIVE SURGICAL, INC. | 5.8% | 4.8% | 4.8% |
|
MERCK & CO., INC. | 4.8% | 4.5% | 4.5% |
|
BOSTON SCIENTIFIC CORPORATION | 5.3% | 4.2% | 4.2% |
Position Highlights (Non-Overlapping Exposures)
BHCHX Overweight Relative to PINK
|
VERTEX PHARMACEUTICALS INCORPORATED | 4.6% |
 |
ARGENX SE ADR | 3.6% |
 |
ICON PLC | 3.2% |
|
STRYKER CORPORATION | 3.0% |
|
STRYKER CORP | 3.0% |
|
ELI LILLY & CO | 2.8% |
|
ELI LILLY AND COMPANY | 2.8% |
|
MCKESSON CORPORATION | 2.7% |
|
ARCELLX, INC. | 2.6% |
|
ROCKET PHARMACEUTICALS, INC. | 2.3% |
BHCHX Underweight Relative to PINK
|
SAREPTA THERAPEUTICS INC | -10.6% |
|
PURECYCLE TECHNOLOGIES INC | -5.8% |
 |
SANOFI-AVENTIS-ADR | -5.0% |
|
REGENERON PHARMACEUTICALS | -4.8% |
 |
NOVO-NORDISK A/S-SPONS ADR | -3.5% |
|
GILEAD SCIENCES INC | -3.1% |
|
3M CO | -3.1% |
|
JOHNSON & JOHNSON | -2.7% |
|
NEUROCRINE BIOSCIENCES INC | -2.3% |
|
PERKINELMER INC | -2.1% |